Region: Global
Category: Biotechnology

Global Biotechnology

(9,451 reports matching your criteria)
  • Global Cell and Gene Therapy Market Growth (Status and Outlook) 2024-2030

    ... growing demand in downstream market, the Cell and Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More

  • Immunofluorescence Assays

    ... at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence Assays Reagents, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.8 Billion by the end ... Read More

  • In Vitro Protein Expression Systems

    ... is expected to reach US$307.5 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. E-Coli, one of the segments analyzed in the report, is expected to record a 5.0% CAGR ... Read More

  • Polymerase Chain Reaction Consumables

    ... reach US$606.9 Million by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. PCR Tubes, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach ... Read More

  • Cancer Stem Cells

    ... by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 ... Read More

  • High Throughput Process Development

    ... reach US$24.6 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Monoclonal Antibodies Molecule Type, one of the segments analyzed in the report, is expected to record a 9.0% CAGR ... Read More

  • Terahertz Technology

    ... at a CAGR of 28.9% over the analysis period 2023-2030. Terahertz Source Technology, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$1.8 Billion by the end ... Read More

  • GMP Cell Banking Services

    ... reach US$2.2 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. Biopharmaceutical Companies End-Use, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and ... Read More

  • Nanomedicine

    ... of 9.8% over the analysis period 2023-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$229.6 Billion by the end of the analysis ... Read More

  • Human Microbiome

    ... at a CAGR of 28.4% over the analysis period 2023-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.7% CAGR and reach US$1.3 Billion by the end of ... Read More

  • Computational Biology

    ... at a CAGR of 18.1% over the analysis period 2023-2030. Contract Services, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$20.1 Billion by the end of ... Read More

  • Humanized Mouse and Rat Model

    ... is expected to reach US$219.4 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Oncology Application, one of the segments analyzed in the report, is expected to record a 8.1% ... Read More

  • Hydrophobic Interaction Chromatography

    ... a CAGR of 6.3% over the analysis period 2023-2030. Chromatography Resins, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$263.1 Million by the end of the ... Read More

  • Cold Plasma

    ... at a CAGR of 14.7% over the analysis period 2023-2030. Polymer & Plastics End-Use, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the ... Read More

  • CRISPR Technology

    ... CAGR of 21.1% over the analysis period 2023-2030. Products Component, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$6.1 Billion by the end of the analysis ... Read More

  • Mammalian Polyclonal IgG Antibody

    ... 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Metabolic Markers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$532.1 Million by the ... Read More

  • Soft Tissue Allografts

    ... at a CAGR of 4.9% over the analysis period 2023-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More

  • Combination Antibody Therapy

    ... by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$215.4 Billion ... Read More

  • Genomics

    ... of 19.0% over the analysis period 2023-2030. Sequencing Technology, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$106.1 Billion by the end of the analysis period. ... Read More

  • Chiral Chromatography Column

    ... by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Pharmaceutical & Biotechnology End-Use, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$54.2 ... Read More

  • Competent Cells

    ... at a CAGR of 7.9% over the analysis period 2023-2030. Cloning Application, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.0 Billion by the end of ... Read More

  • Genome Editing / Genome Engineering

    ... is expected to reach US$37.2 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2023-2030. Genetic Engineering Application, one of the segments analyzed in the report, is expected to record a ... Read More

  • Human Liver Models

    ... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Drug Discovery Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$225.8 Million ... Read More

  • Oligonucleotide Synthesis

    ... at a CAGR of 15.7% over the analysis period 2023-2030. Oligonucleotide-Based Drugs, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$8.6 Billion by the end of ... Read More

  • Stem Cell Services

    ... by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. The U.S. Market is Estimated at US$7.5 Billion While China is Forecast to Grow at 9.0% CAGR The Stem Cell Services market ... Read More

Cookie Settings